Tuesday, November 29, 2022
Tags Cancer Research

Tag: Cancer Research

The Pap Corps 70th Anniversary Committee

The Pap Corps Champions for Cancer Research Celebrates 70 Years of Funding Research for All Types of Cancer

DEERFIELD BEACH, Fla. /FLORIDA NEWSWIRE/ -- The Pap Corps Champions for Cancer Research will celebrate its 70th anniversary with a beautiful luncheon event at the Polo Club in Boca Raton on Tuesday, November 15, 2022. During the past seven decades, the nonprofit has grown from a small group of women supporting the pioneering work of Dr. George Papanicolaou to a dynamic organization with over 20,000 members, who fund research for all types of cancer at Sylvester Comprehensive Cancer Center.
Members of The Pap Corps and Sylvester Comprehensive Cancer Center

Nonprofit The Pap Corps Donates $3.5M to Sylvester Comprehensive Cancer Center

DEERFIELD BEACH, Fla. /FLORIDA NEWSWIRE/ -- You can't keep champions down! Rebounding from COVID-19, The Pap Corps Champions for Cancer Research came back full swing with their fundraising for the 2021/2022 fiscal year. At their May meeting, the 501(c)(3) nonprofit donated $3.5 million to Sylvester Comprehensive Cancer Center.

NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor

CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.

Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board

CAMBRIDGE, Mass., Sept. 2, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company's Scientific Advisory Board.

Mira and the National Foundation for Cancer Research to expand COVID Care and tackle health disparities

NEW YORK, N.Y., April 13, 2020 (SEND2PRESS NEWSWIRE) -- Mira, a healthcare company based in NYC, is partnering with the National Foundation for Cancer Research (NFCR) to provide COVID Care to cancer patients and caregivers, bringing healthcare closer to those who need it the most.

iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting

STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
The Pap Corps Receives $100K Matching Gift

The Pap Corps Receives $100K Matching Gift Challenge by The Yass Family

BOCA RATON, Fla. /Florida Newswire/ -- The Pap Corps Champions for Cancer Research has announced a $100,000 matching gift challenge by The Yass Family. This gift will be utilized to enhance the 2018 Dr. Kevin Berkowitz Memorial End of Year Giving Campaign, which will be directed towards melanoma research at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

Nationally Renowned Research Doctor Will Discuss His New Hopes, Methods, and Successes with Treating Rare Children’s Cancers on Nov. 5, 2017

LAKE FOREST, Calif., July 15, 2017 (SEND2PRESS NEWSWIRE) -- Jareds Juggernaut To Cure Sarcoma, a non-profit which funds researchers of body sparing cancer treatments targeted for rare children's cancers, today announced an event which features Dr. Charles Keller as the keynote speaker, which will take place on November 5, 2017 in the Sun and Sail Club in Lake Forest, Calif.

Weitz and Luxenberg, P.C. Sees Cancer Research Month As Ideal Time to Provide Free Access to Cancer Study Data

NEW YORK, N.Y., May 15, 2016 (SEND2PRESS NEWSWIRE) -- Weitz & Luxenberg, P.C. today said it agrees with Vice President Joe Biden that the lives of more cancer victims could be saved if cancer researchers were able to more freely access published studies and, most importantly, their underlying data.

FEATURED NEWS

NATIONAL NEWS